Please select the option that best describes you:
Topics:
Gynecologic Oncology • Uterine Cancer
What is your surveillance strategy for uterine smooth muscle tumors of uncertain malignant potential (STUMP) and atypical leiomyoma identified on hysterectomy?
Does your surveillance strategy differ if this was identified on a morcellated specimen vs after myomectomy?